Literature DB >> 30369428

The Placenta in Neonatal Encephalopathy: A Case-Control Study.

Torstein Vik1, Raymond Redline2, Karin B Nelson3, Solveig Bjellmo4, Christina Vogt5, Pamela Ng6, Kristin Melheim Strand7, Tuyet Nhung Ton Nu8, Maryam Oskoui9.   

Abstract

OBJECTIVE: We assessed whether specific histologic placental lesions were associated with risk for neonatal encephalopathy, a strong predictor of death or cerebral palsy. STUDY
DESIGN: Case-control study of singletons with gestational ages ≥35 weeks. Data were abstracted from a prospectively collected database of consecutive births at a hospital in which placental samples from specified sites are collected and stored for all inborn infants. Placentas of infants with neonatal encephalopathy were compared with randomly selected control infants (ratio of 1:3). Placental histologic slides were read by a single experienced perinatal pathologist unaware of case status, using internationally recommended definitions and terminology. Findings were grouped into inflammatory, maternal, or fetal vascular malperfusion (FVM) and other lesions.
RESULTS: Placental samples were available for 73 of 87 (84%) cases and 253 of 261 (97%) controls. Delivery complications and gross placental abnormalities were more common in cases, of whom 4 died. Inflammation and maternal vascular malperfusion did not differ, and findings consistent with global FVM were more frequent in case (20%) than control (7%) placentas (P = .001). There was a trend toward more segmental FVM and high-grade FVM (fetal thrombotic vasculopathy) among cases. Some type of FVM was observed in 24% of placentas with neonatal encephalopathy. In infants with both neonatal encephalopathy and placental FVM, more often than in infants with neonatal encephalopathy without FVM, electronic fetal monitoring tracings were considered possibly or definitely abnormal (P = .028).
CONCLUSIONS: Vascular malperfusion of subacute or chronic origin on the fetal side of the placenta was associated with increased risk of neonatal encephalopathy.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  avascular villi; electronic fetal monitoring; fetal growth restriction; fetal thrombotic vasculopathy; fetal vascular malperfusion; placental weight

Mesh:

Year:  2018        PMID: 30369428     DOI: 10.1016/j.jpeds.2018.06.005

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  8 in total

1.  Relationship Between Placental Weight and Placental Pathology With MRI Findings in Mild to Moderate Hypoxic Ischemic Encephalopathy.

Authors:  Kelley Z Kovatis; Amy Mackley; Michael Antunes; Phoebe J Holmes; Reza J Daugherty; David Paul
Journal:  Cureus       Date:  2022-05-09

2.  Effects of Tissue Temperature and Injury on ADC during Therapeutic Hypothermia in Newborn Hypoxic-Ischemic Encephalopathy.

Authors:  C Zenobi; J L Wisnowski; B Tamrazi; A M-C Wong; R Chapman; S Blüml; T-W Wu
Journal:  AJNR Am J Neuroradiol       Date:  2022-02-03       Impact factor: 3.825

3.  Different antecedents and neonatal condition in neonatal arterial ischemic stroke and hypoxic-ischemic neonatal encephalopathy.

Authors:  Laura Lambicchi; Sara Ornaghi; Giulia Dal Molin; Giuseppe Paterlini; Davide P Bernasconi; Francesca Moltrasio; Patrizia Vergani
Journal:  Int J Gynaecol Obstet       Date:  2021-06-22       Impact factor: 4.447

4.  Placental assessment provides insight into mechanisms and timing of neonatal hypoxic-ischemic encephalopathy.

Authors:  Joseph J Volpe
Journal:  J Neonatal Perinatal Med       Date:  2019

5.  Integrating neuroimaging biomarkers into the multicentre, high-dose erythropoietin for asphyxia and encephalopathy (HEAL) trial: rationale, protocol and harmonisation.

Authors:  Jessica L Wisnowski; Stefan Bluml; Ashok Panigrahy; Amit M Mathur; Jeffrey Berman; Ping-Sun Keven Chen; James Dix; Trevor Flynn; Stanley Fricke; Seth D Friedman; Hayden W Head; Chang Y Ho; Beth Kline-Fath; Michael Oveson; Richard Patterson; Sumit Pruthi; Nancy Rollins; Yanerys M Ramos; John Rampton; Jerome Rusin; Dennis W Shaw; Mark Smith; Jean Tkach; Shreyas Vasanawala; Arastoo Vossough; Matthew T Whitehead; Duan Xu; Kristen Yeom; Bryan Comstock; Patrick J Heagerty; Sandra E Juul; Yvonne W Wu; Robert C McKinstry
Journal:  BMJ Open       Date:  2021-04-22       Impact factor: 2.692

Review 6.  What is known about neuroplacentology in fetal growth restriction and in preterm infants: A narrative review of literature.

Authors:  Barbara Gardella; Mattia Dominoni; Annachiara Licia Scatigno; Stefania Cesari; Giacomo Fiandrino; Simona Orcesi; Arsenio Spinillo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-19       Impact factor: 6.055

7.  Does caesarean delivery in the first pregnancy increase the risk for adverse outcome in the second? A registry-based cohort study on first and second singleton births in Norway.

Authors:  Solveig Bjellmo; Guro L Andersen; Sissel Hjelle; Kari Klungsøyr; Lone Krebs; Stian Lydersen; Pål Richard Romundstad; Torstein Vik
Journal:  BMJ Open       Date:  2020-08-23       Impact factor: 2.692

8.  SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID-19-positive mothers.

Authors:  Jonathon L Hecht; Bradley Quade; Vikram Deshpande; Mari Mino-Kenudson; David T Ting; Niyati Desai; Beata Dygulska; Taryn Heyman; Carolyn Salafia; Dejun Shen; Sara V Bates; Drucilla J Roberts
Journal:  Mod Pathol       Date:  2020-08-02       Impact factor: 8.209

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.